Please login to the form below

Not currently logged in
Email:
Password:

Bydureon

This page shows the latest Bydureon news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Blincyto another option in ALL alongside Kymriah, AZ approval for Bydureon

Daily Brief: Blincyto another option in ALL alongside Kymriah, AZ approval for Bydureon

The new once-weekly formulation called Bydureon BCise uses a new simpler injection device, and was approved in the US in October. ... Sales of Bydureon shrank 2% in the first half of 2018, thanks to a combination of US pricing pressure and growing

Latest news

More from news
Approximately 2 fully matching, plus 41 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2016 Deal Watch October 2016

    150. AstraZeneca (UK). 3SBio. Distribution. Byetta, Bydureon (exanatide) for Type 2 diabetes in China.

  • Interview: Christopher Boulton, AstraZeneca Interview: Christopher Boulton, AstraZeneca

    This was then expanded in 2012 when the alliance acquired Amylin, gaining the rights to a portfolio of products for type 2 diabetes, including the exenatide franchise (Byetta and Bydureon).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

COVID-19 is redefining the value of ‘critical jobs’: An opportunity for social care?
...
How to keep your weight under control during lockdown
...
Brands stepping up to show solidarity during COVID-19
The brands that are stepping up to show solidarity during COVID-19 will be those that are remembered long after pandemic passes....

Infographics